… published Valsartan in Acute Myocardial Infarction Trial (… for use in the high-risk, post-myocardial
infarction (MI) patient … Heart Failure Trial (Val-HeFT) [8], which used valsartan (target …

… be used to stratify individuals at risk for remodelling, a patient … In PROVE-HF, sacubitril/valsartan
in HFrEF patients led to … in patients at risk for heart failure after myocardial infarction in …

… treatment in post-MI heart failure. Data from AIRE study [7]. … aspirin usage. This study was
also notable for evaluating, in particular, … Valsartan, captopril, or both in myocardial infarction …

… the efficacy of sacubitril/valsartan over angiotensin-converting enzyme … of heart failure (HF)
in post-MI patients and providing a clear evidence-based medicine guideline for future use. …

… for Sacubitril/Valsartan in heart failure and post-myocardial infarction remodeling, using an
… myocardial infarction in swine was analyzed to address post-infarction ventricular remodeling…

… infarction are at a high risk of developing heart failure. The … sacubitril/valsartan 97/103 mg
twice daily with valsartan 160 … A strength of the present trial was the use of valsartan as the …

… valsartan and focus on its safety and tolerability profile. The main large-scale studies in
hypertension, heart failure, post-myocardial infarction … Valsartan has been widely used in patients …

… in post-myocardial infarction (MI) and heart failure (HF… infarct size reduction with treatment
could be due to different species, ischemic procedure and techniques used to calculate infarct …

… , heart failure (HF) and post-myocardial infarction (MI). This review focuses on what was
learned from the valsartan clinical … use of RAAS inhibitors: heart failure (HF), post-myocardial …

… The use of valsartan has the advantage that results of a number of large-scale trials … valsartan
soon. VALIANT, which had been studying the role of valsartan in post-myocardial infarction …